Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Shirofune Wins Gold in the 2025 ANA Marketing Technology Awards
-
CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning
-
FluidForm Bio™ Announces Participation in Venture Summit West
-
IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
-
Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
-
Community “Angels" Help Kids, Families, Seniors, Veterans and the Unhoused to Receive Free Vision Care and More
-
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Norden Crown Announces Name Change to Domestic Metals Corp.
-
Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with
-
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site
-
ProStar and Emlid Partner to Deliver Centimeter Accuracy for Critical Infrastructure Mapping Worldwide
-
electroCore Extends VA Contract for Five Years
-
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference
-
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
-
Rapid7 Recognizes Top Global Partners With 2025 Partner Of The Year Awards
-
Synergy CHC Reports its Eighth Consecutive Quarter of Profitability and its Fourth Quarter and Full Year 2024 Financial Results
-
Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates
-
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
-
Australian Oilseeds Announces Second Quarter Fiscal 2025 Financial Results
-
Luckin Coffee Files 2024 Annual Report on Form 20-F
-
Biora Therapeutics Successfully Completes Restructuring Process
-
360 Privacy Announces Strategic Executive Appointments Following $36 Million Growth Investment
-
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
-
Nasdaq Champions Smart Regulatory Reform to Strengthen the World’s Leading Capital Markets and Drive American Economic Growth
-
Clip Money Inc. Reports 2024 Year End Results
-
Emergent BioSolutions Announces Stock Repurchase Program
-
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
-
Community “Angels" Help Kids, Families, Seniors, Veterans and the Unhoused to Receive Free Vision Care and More
-
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
-
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
-
Trump Media to Debut on New York Stock Exchange Texas
-
BetterLife Pharma Appoints New Director
-
GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan
-
Veritex Holdings, Inc. Announces Extension of Stock Buyback Program
-
Tax Season Scams: Regula Unveils the Tax Fraud Awareness Guide to Help Americans Safeguard Their Identity
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
-
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
JDE Peet’s share buyback periodic update March 31, 2025
-
Awilco Drilling PLC: Notice of Extraordinary General Meeting
-
ASML reports transactions under its current share buyback program
-
Regenx Announces Non-Brokered Financing for Gross Proceeds of $679,032
-
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)
-
BIO-key Partners with Arrow ECS Iberia to Strengthen Access to its Identity and Access Management Solutions in Spain and Portugal
-
Transactions in connection with share buyback programme
-
Intetics Ranks Among America’s Most Innovative Companies for 2025 – A True Tech Leader
-
Steakholder Foods Reports 2024 Financial Results and Provides Business Update
-
Edible Garden Reports 181.3% Year-over-Year Gross Profit Increase for 2024
